FANCD2 and squamous cell carcinoma: In experiments treating orthotopic tumors derived from the TC1 squamous cell carcinoma cell line (derived from C57BL/6J mice), single fraction or fractionated irradiation of mice with palpable tumors was successful in Fancd2−/−, heterozygote, and control Fancd2+/+ mice.